Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Walker

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
AIDS Research and Human Retroviruses|May 1, 1996
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infectionT Harrer, E Harrer, S A Kalams, et al.
Journal of Virology|February 1, 1997
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognitionC C Wilson, S A Kalams, B M Wilkes, et al.
Immunology Letters|October 12, 2001
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variationP J Goulder, C Pasquier, E C Holmes, et al.
Journal of Virology|April 6, 2007
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progressionA J Frater, H Brown, A Oxenius, et al.
JAMA|September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infectionS J Little, E S Daar, R T D'Aquila, et al.
The Journal of Experimental Medicine|January 10, 2001
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infectionP J Goulder, M A Altfeld, E S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosityP O Flores-Villanueva, E J Yunis, J C Delgado, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Antiretroviral resistance during successful therapy of HIV type 1 infectionJ Martinez-Picado, M P DePasquale, N Kartsonis, et al.
Journal of Virology|November 13, 1999
Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequencesC Brander, O O Yang, N G Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Vpr is preferentially targeted by CTL during HIV-1 infectionM Altfeld, M M Addo, R L Eldridge, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
AIDS Research and Human Retroviruses|May 1, 1996
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infectionT Harrer, E Harrer, S A Kalams, et al.
Journal of Virology|February 1, 1997
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognitionC C Wilson, S A Kalams, B M Wilkes, et al.
Immunology Letters|October 12, 2001
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variationP J Goulder, C Pasquier, E C Holmes, et al.
Journal of Virology|April 6, 2007
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progressionA J Frater, H Brown, A Oxenius, et al.
JAMA|September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infectionS J Little, E S Daar, R T D'Aquila, et al.
The Journal of Experimental Medicine|January 10, 2001
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infectionP J Goulder, M A Altfeld, E S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2001
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosityP O Flores-Villanueva, E J Yunis, J C Delgado, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Antiretroviral resistance during successful therapy of HIV type 1 infectionJ Martinez-Picado, M P DePasquale, N Kartsonis, et al.
Journal of Virology|November 13, 1999
Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequencesC Brander, O O Yang, N G Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Vpr is preferentially targeted by CTL during HIV-1 infectionM Altfeld, M M Addo, R L Eldridge, et al.
Pageof 17